Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer.
作者信息
Verma Vivek, Chang Joe Y
机构信息
Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
出版信息
J Thorac Dis. 2018 Jan;10(1):21-24. doi: 10.21037/jtd.2017.11.141.
Abstract
摘要
相似文献
1
Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer.立体定向消融放疗治疗寡转移非小细胞肺癌
J Thorac Dis. 2018 Jan;10(1):21-24. doi: 10.21037/jtd.2017.11.141.
2
Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy.寡转移非小细胞肺癌：立体定向消融放疗的叙述性综述。
Ann Palliat Med. 2021 May;10(5):5944-5953. doi: 10.21037/apm-20-1409. Epub 2021 Feb 23.
3
Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.放射治疗作为寡转移非小细胞肺癌局部消融治疗的结果
Cancers (Basel). 2021 Nov 18;13(22):5773. doi: 10.3390/cancers13225773.
4
The Management of Oligometastases in Non-small Cell Lung Cancer - is Stereotactic Ablative Radiotherapy now Standard of Care?非小细胞肺癌寡转移的管理——立体定向消融放疗是否成为标准治疗？
Clin Oncol (R Coll Radiol). 2022 Nov;34(11):753-760. doi: 10.1016/j.clon.2022.08.033. Epub 2022 Sep 16.
5
6
Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.寡转移非小细胞肺癌的消融治疗。
Clin Lung Cancer. 2017 Nov;18(6):595-606. doi: 10.1016/j.cllc.2017.03.002. Epub 2017 Mar 14.
7
Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR).寡转移非小细胞肺癌（NSCLC）行立体定向消融放疗时的内镜下淋巴结分期（ENDO-SABR）。
BMC Cancer. 2022 Apr 28;22(1):468. doi: 10.1186/s12885-022-09563-8.
8
Local ablative radiotherapy for oligometastatic non-small cell lung cancer.寡转移非小细胞肺癌的局部消融放疗
Radiat Oncol J. 2019 Sep;37(3):149-155. doi: 10.3857/roj.2019.00514. Epub 2019 Sep 30.
9
[Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].[立体定向体部放射治疗寡转移非小细胞肺癌（NSCLC）：一例报告]
Cancer Radiother. 2015 May;19(3):192-7. doi: 10.1016/j.canrad.2014.12.007. Epub 2015 Apr 1.
10
Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.立体定向消融放疗治疗寡转移结直肠癌患者的肺转移：长期随访后的结果和预后因素
Clin Colorectal Cancer. 2017 Mar;16(1):58-64. doi: 10.1016/j.clcc.2016.07.004. Epub 2016 Jul 18.
引用本文的文献
1
New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights.不可切除的早期肺癌治疗新视角：临床医生、物理学家和生物学家揭示策略与见解。
J Liq Biopsy. 2024 Mar 28;5:100153. doi: 10.1016/j.jlb.2024.100153. eCollection 2024 Sep.
2
Current status of stereotactic ablative body radiotherapy in the UK: six years of progress.英国立体定向消融体部放射治疗的现状：六年进展
BJR Open. 2019 Jul 19;1(1):20190022. doi: 10.1259/bjro.20190022. eCollection 2019.
3
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment.放疗在肿瘤基质和微环境调控中的作用。
Front Immunol. 2019 Feb 15;10:193. doi: 10.3389/fimmu.2019.00193. eCollection 2019.
4
Palliative radiotherapy.姑息性放疗
BMJ. 2018 Mar 23;360:k821. doi: 10.1136/bmj.k821.
5
Patterns of initial and intracranial failure in metastatic EGFR-mutant non-small cell lung cancer treated with erlotinib.厄洛替尼治疗转移性表皮生长因子受体（EGFR）突变非小细胞肺癌的初始及颅内失败模式
Lung Cancer. 2017 Jun;108:109-114. doi: 10.1016/j.lungcan.2017.03.010. Epub 2017 Mar 24.
本文引用的文献
1
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.局限性转移性非小细胞肺癌的巩固性放疗：一项 2 期随机临床试验。
JAMA Oncol. 2018 Jan 11;4(1):e173501. doi: 10.1001/jamaoncol.2017.3501.
2
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).肺癌伴脑转移患者生存预测：基于分子标志物的肺癌预后分级评估（Lung-molGPA）的更新。
JAMA Oncol. 2017 Jun 1;3(6):827-831. doi: 10.1001/jamaoncol.2016.3834.
3
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.一线全身治疗后无进展的寡转移性非小细胞肺癌患者的局部巩固治疗与维持治疗或观察比较：一项多中心、随机、对照、2期研究
Lancet Oncol. 2016 Dec;17(12):1672-1682. doi: 10.1016/S1470-2045(16)30532-0. Epub 2016 Oct 24.
4
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.帕博利珠单抗对比化疗用于 PD-L1 阳性非小细胞肺癌。
N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8.
5
Implications of the Bystander and Abscopal Effects of Radiation Therapy.放疗的旁观者效应和远隔效应的意义。
Clin Cancer Res. 2016 Oct 1;22(19):4763-4765. doi: 10.1158/1078-0432.CCR-16-1512. Epub 2016 Jul 25.
6
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?免疫疗法与立体定向消融放疗（ISABR）：一种治愈性方法？
Nat Rev Clin Oncol. 2016 Aug;13(8):516-24. doi: 10.1038/nrclinonc.2016.30. Epub 2016 Mar 8.
7
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.帕博利珠单抗对比多西他赛用于治疗后 PD-L1 阳性的、晚期非小细胞肺癌（KEYNOTE-010）：一项随机对照试验。
Lancet. 2016 Apr 9;387(10027):1540-1550. doi: 10.1016/S0140-6736(15)01281-7. Epub 2015 Dec 19.
8
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant.局部放疗的远隔效应：利用免疫疗法使罕见事件具有临床相关性。
Cancer Treat Rev. 2015 Jun;41(6):503-10. doi: 10.1016/j.ctrv.2015.03.011. Epub 2015 Mar 28.
9
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.局限进展期转移性非小细胞肺癌患者立体定向放疗联合厄洛替尼的Ⅱ期临床试验
J Clin Oncol. 2014 Dec 1;32(34):3824-30. doi: 10.1200/JCO.2014.56.7412. Epub 2014 Oct 27.
10
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival.立体定向放疗治疗寡转移癌：生存预后模型。
Ann Oncol. 2014 Feb;25(2):467-71. doi: 10.1093/annonc/mdt537. Epub 2013 Dec 18.
Zotero 插件